209 related articles for article (PubMed ID: 16689182)
21. Tolerance of immunotherapy with a standardized extract of Alternaria tenuis in patients with rhinitis and bronchial asthma.
Tabar AI; Lizaso MT; García BE; Echechipía S; Olaguibel JM; Rodríguez A
J Investig Allergol Clin Immunol; 2000; 10(6):327-33. PubMed ID: 11206932
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy with a mass unit Parietaria judaica extract: a tolerance study with evidence of immunological changes to the major allergen Par j 1.
García Villalmanzo I; Hernández MD; Campos A; Giner AM; Polo F; Cortés C; Basomba A
J Investig Allergol Clin Immunol; 1999; 9(5):321-9. PubMed ID: 10582201
[TBL] [Abstract][Full Text] [Related]
23. Double-blind, randomized, placebo-controlled trial of allergen-specific immunotherapy with the major allergen Alt a 1.
Tabar AI; Prieto L; Alba P; Nieto A; Rodríguez M; Torrecillas M; Huertas B; Gómez E; Fernández FJ; Blanca M; Rodríguez D; Palacios R
J Allergy Clin Immunol; 2019 Jul; 144(1):216-223.e3. PubMed ID: 30879998
[TBL] [Abstract][Full Text] [Related]
24. Allergen stabilities and compatibilities in mixtures of high-protease fungal and insect extracts.
Grier TJ; LeFevre DM; Duncan EA; Esch RE; Coyne TC
Ann Allergy Asthma Immunol; 2012 Jun; 108(6):439-47. PubMed ID: 22626598
[TBL] [Abstract][Full Text] [Related]
25. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
26. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
27. Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety.
Tabar AI; Lizaso MT; García BE; Gómez B; Echechipía S; Aldunate MT; Madariaga B; Martínez A
Pediatr Allergy Immunol; 2008 Feb; 19(1):67-75. PubMed ID: 17651380
[TBL] [Abstract][Full Text] [Related]
28. Quantitation of the major fungal allergens, Alt a 1 and Asp f 1, in commercial allergenic products.
Vailes L; Sridhara S; Cromwell O; Weber B; Breitenbach M; Chapman M
J Allergy Clin Immunol; 2001 Apr; 107(4):641-6. PubMed ID: 11295652
[TBL] [Abstract][Full Text] [Related]
29. Alternaria as a major allergen for asthma in children raised in a desert environment.
Halonen M; Stern DA; Wright AL; Taussig LM; Martinez FD
Am J Respir Crit Care Med; 1997 Apr; 155(4):1356-61. PubMed ID: 9105079
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy with mosquito (Culex quinquefasciatus) extract: a double-blind, placebo-controlled study.
Srivastava D; Singh BP; Sudha VT; Arora N; Gaur SN
Ann Allergy Asthma Immunol; 2007 Sep; 99(3):273-80. PubMed ID: 17910332
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of efficacy of immunotherapy in children with asthma monosensitized to Alternaria.
Kiliç M; Altintaş DU; Yilmaz M; Bingöl-Karakoç G; Burgut R; Güneşer-Kendirli S
Turk J Pediatr; 2011; 53(3):285-94. PubMed ID: 21980810
[TBL] [Abstract][Full Text] [Related]
32. Respiratory allergy to fungi in Barcelona, Spain: clinical aspects, diagnosis and specific treatment in a general allergy unit.
Torres-Rodríguez JM; Pulido-Marrero Z; Vera-García Y
Allergol Immunopathol (Madr); 2012; 40(5):295-300. PubMed ID: 22136809
[TBL] [Abstract][Full Text] [Related]
33. Is there a role for measurement of nasal IgE antibodies in diagnosis of Alternaria-induced rhinitis in children?
Garas G; Jones N
Allergol Immunopathol (Madr); 2012; 40(2):69-70. PubMed ID: 22266145
[No Abstract] [Full Text] [Related]
34. Component-resolved diagnosis: performance of specific IgE to Alternaria compared to Alt a 1.
Nieto M; Lafuente I; Calderon R; Uixera S; Pina R; Calaforra S; Cortell I; Nieto A; Mazon A
Pediatr Allergy Immunol; 2014 Dec; 25(8):832-4. PubMed ID: 25389066
[No Abstract] [Full Text] [Related]
35. Isolation and expression of a cDNA clone encoding an Alternaria alternata Alt a 1 subunit.
De Vouge MW; Thaker AJ; Curran IH; Zhang L; Muradia G; Rode H; Vijay HM
Int Arch Allergy Immunol; 1996 Dec; 111(4):385-95. PubMed ID: 8957113
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of Alternaria alternata sensitization in patients with allergic rhinitis.
Katotomichelakis M; Anastassakis K; Gouveris H; Tripsianis G; Paraskakis E; Maroudias N; Danielides V
Am J Otolaryngol; 2012; 33(2):232-8. PubMed ID: 21907454
[TBL] [Abstract][Full Text] [Related]
37. Immunotherapy with an extract of Olea europaea quantified in mass units. Evaluation of the safety and efficacy after one year of treatment.
González P; Florido F; Sáenz de San Pedro B; de la Torre F; Rico P; Martín S
J Investig Allergol Clin Immunol; 2002; 12(4):263-71. PubMed ID: 12926186
[TBL] [Abstract][Full Text] [Related]
38. Nonspecific changes in immunotherapy with house dust extract.
García NM; Lynch NR; Di Prisco MC; López RI
J Investig Allergol Clin Immunol; 1995; 5(1):18-24. PubMed ID: 7551200
[TBL] [Abstract][Full Text] [Related]
39. Standardization of Alternaria alternata: extraction and quantification of alt a 1 by using an mAb-based 2-site binding assay.
Aden E; Weber B; Bossert J; Teppke M; Frank E; Wahl R; Fiebig H; Cromwell O
J Allergy Clin Immunol; 1999 Jul; 104(1):128-35. PubMed ID: 10400850
[TBL] [Abstract][Full Text] [Related]
40. Enzymatic activities of Alternaria alternata allergenic extracts and its major allergen (Alt a 1).
Sáenz-de-Santamaría M; Guisantes JA; Martínez J
Mycoses; 2006 Jul; 49(4):288-92. PubMed ID: 16784442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
